Allergen Subcutaneous Immunotherapy (SCIT)
Customize your policy alerts
Sign up for Providence Health Plan Policy 448 alerts
Get alerted when Policy 448 changes without checking for updates manually.
Monitor payer policy activity
Coverage criteria, documentation, limitations, and medical necessity for office-, facility-, and exceptionally home-based allergen SCIT, including rapid desensitization, for applicable Providence commercial products and related Providence entities. Oral or nasal allergy immunotherapy and food allergy treatments are excluded.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.